D. Brabbins

2.1k total citations
41 papers, 1.7k citations indexed

About

D. Brabbins is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Obstetrics and Gynecology. According to data from OpenAlex, D. Brabbins has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 21 papers in Radiation and 10 papers in Obstetrics and Gynecology. Recurrent topics in D. Brabbins's work include Prostate Cancer Diagnosis and Treatment (23 papers), Advanced Radiotherapy Techniques (21 papers) and Prostate Cancer Treatment and Research (16 papers). D. Brabbins is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (23 papers), Advanced Radiotherapy Techniques (21 papers) and Prostate Cancer Treatment and Research (16 papers). D. Brabbins collaborates with scholars based in United States, Romania and Germany. D. Brabbins's co-authors include Alvaro A. Martinez, Di Yan, Frank A. Vicini, David Lockman, Gary Gustafson, Gregory K. Edmundson, L. Tyburski, Larry L. Kestin, John Wong and David A. Jaffray and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

D. Brabbins

41 papers receiving 1.6k citations

Peers

Countries citing papers authored by D. Brabbins

Since Specialization

Citations

This map shows the geographic impact of D. Brabbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Brabbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Brabbins more than expected).

Fields of papers citing papers by D. Brabbins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Brabbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Brabbins. The network helps show where D. Brabbins may publish in the future.

Co-authorship network of co-authors of D. Brabbins

This figure shows the co-authorship network connecting the top 25 collaborators of D. Brabbins. A scholar is included among the top collaborators of D. Brabbins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Brabbins. D. Brabbins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identifying Differences Between Biochemical Failure and Cure: Incidence Rates and Predictors 2011 ·International Journal of Radiation OncologyBiologyPhysics ·Frank A. Vicini, Chirag Shah, Larry L. Kestin, Mihai Ghilezan, Daniel Krauss, Hong Ye, D. Brabbins, Alvaro A. Martinez	6
2	Comparison of Acute and Late Toxicities for Three Modern High-Dose Radiation Treatment Techniques for Localized Prostate Cancer 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Nasiruddin Mohammed, Larry L. Kestin, Mihai Ghilezan, Daniel Krauss, Frank A. Vicini, D. Brabbins, Gary Gustafson, Hong Ye, (unknown)	117
3	Lack of Benefit for the Addition of Androgen Deprivation Therapy to Dose-Escalated Radiotherapy in the Treatment of Intermediate- and High-Risk Prostate Cancer 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Daniel Krauss, Larry L. Kestin, Hong Ye, D. Brabbins, Michel Ghilezan, Gary Gustafson, Frank A. Vicini, Alvaro A. Martinez	50
4	Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Asif Harsolia, Carlos Vargas, Di Yan, D. Brabbins, David Lockman, Jian Liang, Gary Gustafson, Frank A. Vicini, Alvaro A. Martinez, Larry L. Kestin	89
5	A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: Analysis of chronic toxicity 2005 ·International Journal of Radiation OncologyBiologyPhysics ·D. Brabbins, Alvaro A. Martinez, Di Yan, David Lockman, M. Christopher Wallace, Gary Gustafson, Peter Chen, Frank A. Vicini, John Wong	58
6	Vaginal brachytherapy alone: An alternative to adjuvant whole pelvis radiation for early stage endometrial cancer 2005 ·Gynecologic Oncology ·Shruti Jolly, Carlos Vargas, Tushar Kumar, Sheldon Weiner, D. Brabbins, Peter Chen, (unknown), Alvaro A. Martinez	60
7	Interim Results of a Phase II Dose Escalating Trial with Image Guided Adaptive Radiotherapy for the Treatment of Early to High Risk Prostate Cancer Patients: Improved Outcome with Increased EBRT Doses 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Alvaro A. Martinez, Carlos E. Vargas, Larry L. Kestin, Benjamin Thomas, D. Brabbins, David Lockman, John Wong, Di Yan	7
8	HDR vs. LDR (Pd103 permanent implants) brachytherapy as monotherapy for prostate cancer. timing to onset and predictors of erectile dysfunction 2004 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Carlos Vargas, Gary Gustafson, (unknown), M. Balasubramaniam, (unknown), D. Brabbins, Howard Korman, Evelyn Sebastian, Gregory K. Edmundson, (unknown), Alvaro A. Martinez	5
9	Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation 2003 ·Gynecologic Oncology ·Alvaro A. Martinez, Sheldon Weiner, Karl C. Podratz, Ali‐Reza Armin, Jannifer Stromberg, (unknown), Alfred I. Sherman, Mark F. Schray, D. Brabbins	50
10	Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma 2002 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Alvaro A. Martinez, Sheldon Weiner, Karl C. Podratz, Jannifer Stromberg, Mark F. Schray, Christina Mitchell, Alfred I. Sherman, Peter Chen, D. Brabbins	27
11	Long term outcome of adjuvant whole abdominopelvic irradiation for patients with stage I/II endometrial cancer harboring poor histological subtypes including serous-papillary/clear cell 2002 ·International Journal of Radiation OncologyBiologyPhysics ·Daniel Krauss, (unknown), Sheldon Weiner, J.S. Stromberg, (unknown), Jack W. Jennings, (unknown), Alfred I. Sherman, D. Brabbins	4
12	Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer 2001 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Di Yan, David Lockman, D. Brabbins, (unknown), Michael Sharpe, David A. Jaffray, Frank A. Vicini, John Wong	161
13	Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report 2001 ·International Journal of Radiation OncologyBiologyPhysics ·Alvaro A. Martinez, István Pataki, Gregory K. Edmundson, Evelyn Sebastian, D. Brabbins, Gary Gustafson	198
14	An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer 2000 ·International Journal of Radiation OncologyBiologyPhysics ·Di Yan, David Lockman, D. Brabbins, L. Tyburski, Alvaro A. Martinez	265
15	The use of adaptive radiation therapy to reduce setup error: a prospective clinical study 1998 ·International Journal of Radiation OncologyBiologyPhysics ·Di Yan, Ellen L. Ziaja, David A. Jaffray, John W. Wong, D. Brabbins, Frank A. Vicini, Alvaro A. Martinez	115
16	Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: Treatment description and preliminary results of a phase clinical trial 1995 ·International Journal of Radiation OncologyBiologyPhysics ·Jannifer Stromberg, Alvaro A. Martinez, José M. López-Picazo, Gregory K. Edmundson, (unknown), Frank A. Vicini, Jay B. Hollander, Gary Gustafson, W. F. Spencer, Di Yan, D. Brabbins	69
17	Conformal prostate brachytherapy: Initial experience of a phase I/II dose-escalating trial 1995 ·International Journal of Radiation OncologyBiologyPhysics ·Alvaro A. Martinez, Jose A. Gonzalez, Jannifer Stromberg, Gregory K. Edmundson, Marianne Plunkett, Gary Gustafson, (unknown), Di Yan, Frank A. Vicini, D. Brabbins	73
18	Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation 1994 ·International Journal of Radiation OncologyBiologyPhysics ·Jannifer Stromberg, Álvaro Martínez, Ralph C. Benson, Graciela R. Garton, Ananias C. Diokno, José Antonio González, Horst Zincke, Mark F. Schray, Gregory K. Edmundson, D. Brabbins	30
19	Concurrent treatment planning for outpatient high dose rate prostate template implants 1993 ·International Journal of Radiation OncologyBiologyPhysics ·Gregory K. Edmundson, (unknown), (unknown), D. Brabbins, Frank A. Vicini, Alvaro A. Martinez	38
20	Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma 1991 ·International Journal of Radiation OncologyBiologyPhysics ·Susan K. Gibbons, Álvaro Martínez, Mark F. Schray, Karl C. Podratz, (unknown), Graciela R. Garton, Sheldon Weiner, D. Brabbins, George D. Malkasian	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact